Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Effectiveness of Vitamin D3 Supplement to Increase Bone Mineral Density and Decrease Tenofovir-Induced Hyperparathyroidism in HIV Positive Youth Treated with ART Containing Tenofovir
收藏DataCite Commons2022-11-16 更新2024-07-13 收录
下载链接：
https://dash.nichd.nih.gov/study/18343
下载链接
链接失效反馈官方服务：
资源简介：
A randomized, double-blind, placebo-controlled trial of directly observed vitamin D versus placebo every 4 weeks for 48 weeks. Participants included HIV-infected youth ages 16-24 with viral load <200 copies/mL, and taking TDF-containing combination antiretroviral therapy for >180 days. Whole-body, spine, and hip BMD and BMC were assessed using DXA at baseline and at study weeks 24 and 48.
提供机构：
NICHD Data and Specimen Hub
创建时间：
2022-11-15
